Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

allowance for doubtful accounts2.72.3Accretion of preferred stock and contingent consideration obligations21.514.6Contingent consideration fair value adjustment(19.5)-Excess tax benefit from stock-based compensation(13.7)(14.6)Other, net3.3(0.2)Changes in assets and liabilities (net of effects of acquisitions):Accounts receivable, net372.0(590.9)Inventories(6.2)(282.2)Prepaid expenses and other current assets(41.6)43.5Accounts payable and accrued expenses(222.7)671.8Deferred revenue(14.9)(8.7)Income and other taxes payable(192.1)85.5Other assets and liabilities8.7(33.4)Total adjustments567.5372.9Net cash provided by operating activities665.8632.0Cash Flows From Investing Activities:Additions to property and equipment(137.5)(126.7)Additions to product rights and other intangibles(9.0)(18.7)Additions to investments(5.2)(13.6)Proceeds from sales of property and equipment8.06.7Proceeds from sales of marketable securities and other investments58.96.1Proceeds from sales of divested products232.5-Acquisition of business, net of cash acquired(5,742.8)(575.1)Investment in foreign exchange derivatives(156.7)-Other investing activities, net2.82.3Net cash used in investing activities(5,749.0)(719.0)Cash Flows From Financing Activities:Proceeds from issuance of long-term debt5,665.5-Proceeds from borrowings on credit facility375.0400.0Debt issuance costs(77.8)-Payments on debt, including capital lease obligations(679.7)(428.8)Proceeds from stock plans18.854.9Payment of contingent consideration(105.3)(4.5)Repurchase of common stock(16.1)(14.2)Acquisition of noncontrolling interest(4.5)(5.6)Excess tax benefit from stock-based compensation13.714.6Net cash provided by financing activities5,189.616.4Effect of currency exchange rate changes on cash and cash equivalents3.3(2.9)Net (decrease) increase in cash and cash equivalents109.7(73.5)Cash and cash equivalents at beginning of period209.3282.8Cash and cash equivalents at end of period$
319.0$
209.3 

The following
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Report Details   ... R&D progress, and predicted revenues ,Where is the market ... commercial prospects for this market and related technologies? Visiongain,s ... trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to restore ...
(Date:2/27/2015)... ON , Feb. 27, 2015 /CNW/ - Covalon Technologies ... medical technologies company, today announced financial results for its ... For the three months ended December 31, 2014, revenue ... the quarter was $229,820 or $0.02 per share.  ... , said "I am very pleased with the significant ...
(Date:2/27/2015)... February 27, 2015 ... Überwachungssystem für kongestive Herzinsuffizienz (CHF) in seiner ...     Die ... neuartiges Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz ... sie ein Finanzierungsvorhaben über 5 Mio. USD ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... 26, 2011 Endo Pharmaceuticals Holdings Inc. (NASDAQ: ... aggregate principal amount of senior unsecured notes. The notes will ... guaranteed by certain of the Company,s subsidiaries.   ... together with cash on hand and borrowings under its new ...
... May 26, 2011 Hospital and health-system pharmacies ... shortages and promote patient safety with the support ... Technicians (CPhTs). Manufacturing issues, including shortages ... limited manufacturing capacity, and pharmaceutical industry consolidation, have ...
Cached Medicine Technology:Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes 2Pharmacy Technicians Assist Pharmacy Teams in Development of Drug Shortage Protocols 2
(Date:2/28/2015)... Toronto, ON (PRWEB) February 28, 2015 ... the Art of Facial Surgery was recently featured in ... 82 of the magazine, Dr. David Ellis was featured ... He discussed the various cosmetic enhancements that Kim Cattrall ... skin. , “Her forehead is smooth without horizontal ...
(Date:2/28/2015)... “ Powermod ” was featured on NewsWatch as ... at the latest and coolest technology products and services available ... a technology expert, conducted the review and shared with viewers ... Getting stuck with a low battery and no way to ... face on a daily basis. Even when a person does ...
(Date:2/28/2015)... February 28, 2015 The World Scout ... learning materials to potential EMTs and firefighters, recently announced ... as a way to raise charitable donations for age-related ... Medellin, Columbia, will be held on March 29, 2015; ... will begin at 3:30 p.m. , To participate ...
(Date:2/27/2015)... Hispanics develop alcoholic liver disease (ALD), ... 12 years earlier than Whites/Caucasians or African Americans, according ... , While previous research indicated that Hispanics tend to ... study -- published online in the journal Alcoholism: Clinical ... first to pinpoint racial and ethnic disparities in the ...
(Date:2/27/2015)... A new study published in the ... who cycle on a regular basis and prostate cancer. While ... that the more hours per week a man spends cycling, ... to an increased importance on prostate cancer screening methods. , ... more closely at patents’ risk factors for developing prostate cancer,” ...
Breaking Medicine News(10 mins):Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3
... Online Science Writers Webinar , NCI and ASCO will ... Wide Web that will explore key issues surrounding cancer ... experts from the United States, Africa, Asia and India ... Incidence, Survival and Mortality Trends , The State ...
... planning proton treatments makes it possible to precisely ... distributed inside the patient,s body, PALO ALTO, Calif., ... has received FDA 510(k) clearance for a new proton,scanning ... beams are used to target tumors and other abnormalities. ...
... Reliable, Quick Patient-Information Retrieval From Multiple ... Ill., Dec. 14 AT&T Inc. (NYSE: ... Associates, Ltd. (JOHA) has,awarded AT&T a three-year ... addition to other network solutions. Continuing its ...
... AMSTERDAM, December 14 Kiadis Pharma announced ... for regulatory,classification as a "cell based" medicinal product ... the European Medicines Agency (EMEA). Based upon,this regulatory ... a,next step Kiadis Pharma will file for orphan ...
... Online Help for Living Longer, ... Stronger, KIRKLAND, ... odds of needing long term care,increase. One solution is long term care insurance ... Financial Partners,(LTCFP), "is the insurance plus health habits to keep yourself on your ...
... generation begins to join the ranks of the retired so ... consumers, says a new study funded by the Economic and ... media creations, it seems that the caricatures of silver surfers ... of older people increasingly mirror those of the rest of ...
Cached Medicine News:Health News:NCI/ASCO host science writers' seminar 2Health News:Eclipse(TM) Proton Scanning Algorithm from Varian Medical Systems Receives FDA Clearance 2Health News:Eclipse(TM) Proton Scanning Algorithm from Varian Medical Systems Receives FDA Clearance 3Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 2Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 3Health News:ATIR Classified as "Cell Based" Medicinal Product by the EMEA 2Health News:As More Americans Live to 100, Long Term Care Insurance Leader Gives Health Assist 2Health News:Retirees spending freely 2
... optical performance, the ALM X'Ten is a ... types of applications. , ,Its unique cross-shaped ... the highest standards needed for your surgical ... within the surgical field., ,A 31" column ...
The very bright medical maginifier lamp for examination and labratory....
... Closure Deviceprotects surgeons, nurses, and OR ... threat of disease from deadly bloodborne ... same time enabling Gold Standard wound ... The SuturTek 360Fascia Closure Devicealso protects ...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment....
Medicine Products: